This European funding aims to deepen the understanding of human skin development and associated skin diseases. The DevSkin project seeks to identify the mechanisms governing skin formation and maturation, in order to create in vitro models that better replicate its regional heterogeneity.
Alain Chédotal, head of the 'Human Embryology, Normal and Pathological' team at the Mechanisms in Integrative Living Sciences (MeLiS) laboratory, is recognized for his pioneering work in tissue clearing and 3D imaging applied to human embryology. His laboratory has also established a biobank of embryonic and fetal tissues.
The lack of knowledge regarding the molecular mechanisms that determine regional skin differences during prenatal development limits the creation of physiologically relevant in vitro skin models and the understanding of regional vulnerabilities to certain diseases such as atopic dermatitis or psoriasis.
« Our goal is to establish a comprehensive knowledge base to understand human skin development, with direct clinical implications for congenital, postnatal, and adult-onset skin diseases, which represent a major health and socio-economic challenge », explained Alain Chédotal.
The DevSkin project relies on a multidisciplinary approach bringing together international experts in skin biology (Muzlifah Haniffa, University of Cambridge, UK), developmental biology (Olivier Pourquié, Harvard University, USA), and artificial intelligence (Maria Colomé-Tatché, Hospital del Mar Research Institute, Spain). These researchers, from laboratories with complementary expertise, will undertake an unprecedented scientific effort to advance skin regenerative engineering.




